Blog
Are Cancer Trials Too Intimidating For Patients?
A new study released by the international journal Sociology of Health and Illness shows that cancer trials are too long, filled with jargon, and can be intimidating. The study consisted of 13 cancer trials and 26 patients. The authors of the study found that the...
Pharma shifts focus from small molecules to biologics
In the last 5 years, big pharma has continued its move toward large molecules and biologics for drug development. Two recent studies from Withers & Rogers (a UK law firm specializing in IP) and KMR Group (a pharma consultancy) report on some of the trends among...
IOM report responds to Duke research, calls for greater “omics” oversight
In the wake of the recent commotion surrounding flawed research at Duke University on diagnostic tools based on molecular patterns (“omics” tests), an Institute of Medicine (IOM) panel has issued a report entitled Evolution of Translational Omics: Lessons Learned and...
FDA issues warning letter to clinical investigator studying marketed drugs
FDA recently issued a warning letter to clinical investigator Betty Tuller, PhD, after she purportedly violated several requirements under 21 CFR Part 312 while working at Florida Atlantic University’s Center for Complex Systems and Brain Sciences. According to the...
St. Vincent’s Health to hold Eighth Annual Research Symposium
Save the date Wednesday June 13, 2012 for the Eighth Annual Research Symposium by St. Vincent Health. The event will go from 7:00am-4:00pm at the Lilly Conference Center at the Marten House. The main topics will be regulatory updates, family medicine, women's...